• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCULAR SOLUTIONS, INC LANGSTON V2; DUAL LUMEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCULAR SOLUTIONS, INC LANGSTON V2; DUAL LUMEN Back to Search Results
Model Number 5540
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 10/12/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A manufacturing record review was completed and zero nonconformances were found.This event is related to mdr 2134812-2017-00090.No patient impact or injury was reported for either of these complaints.The unit for this complaint was sent to the supplier for further investigation.These complaints are under further investigation.A follow-up report will be initiated if additional or further information is received.
 
Event or Problem Description
During the procedure experienced air drawing back from the engaged catheter while flushing and prepping to zero the line.An unusual blue segment of catheter was noted to be extending from the yellow segment of the catheter.The catheter was removed and another langston was used successfully to complete the case without incident.No patient impact or injury reported.Mdr 2134812-2017-00090 is associated to this report.
 
Additional Manufacturer Narrative
This event is related to mdr 2134812-2017-00090 langston v2 and mdr 2134812-2017-00076 langston v2.The returned product evaluation confirmed the hub of the catheter was separated from the strain relief.A leak test was performed on the returned unit and the results show that injecting through the ao (aortic) port produced a leak at the point of separation, between the proximal hub/strain relief bond.Furthermore, a liquid leakage under pressure test was completed on test units.Test results concluded that the most likely root cause for this failure is that a high pressure injection was attempted through the ao port causing the bond to separate.The langston ifu precautions; "do not use the outer lumen for the delivery or infusion of diagnostic, embolic, therapeutic materials or to perform pressure injections of contrast medium into the vascular system as such pressure injections could result in device damage.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LANGSTON V2
Common Device Name
DUAL LUMEN
Manufacturer (Section D)
VASCULAR SOLUTIONS, INC
6464 sycamore court north
minneapolis MN 55369
MDR Report Key7018110
Report Number2134812-2017-00091
Device Sequence Number1394147
Product Code DQO
UDI-Device IdentifierM20655400
UDI-PublicM20655400
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
K051395
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,user f
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Physician
Device Expiration Date06/22/2019
Device Model Number5540
Device Lot Number610118
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/16/2017
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer Not provided
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date11/10/2017
Supplement Report FDA Received Date03/06/2018
Patient Sequence Number1
-
-